SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Novus Therapeutics Q3 EPS $(0.22) Up From $(0.37) YoY

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(0.22) per share. This is a 40.54 percent increase over losses of $(0.37) per share from the same period last year.

Benzinga · -

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(0.22) per share. This is a 40.54 percent increase over losses of $(0.37) per share from the same period last year.